Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A growing number of transplant programs are barring patients who refuse COVID vaccines or giving them lower priority on waiting lists.
Yes! An Alabama program allows organs to be transplanted from donors with hepatitis C into recipients who don’t have the virus.
The booster is recommended for organ transplant recipients, people receiving cancer treatment and people with advanced or untreated HIV.
Trial will assess antibody response in people who did not respond to two-dose regimen.
Experts call for heightened precautions and better, more intensive therapies for COVID-19 patients with weakened immune systems.
Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.
For Black people, insurance access, travel distance and a lack of knowledge about options contribute to transplant waiting list disparities.
Especially from people who might have been considered a risk for transmitting HIV and hepatitis B and C
Traditionally, the policy has effectively favored those waiting for a liver in rural areas.
An analysis of nearly 8,000 heart transplants found that whether or not the donor had hepatitis C, 90% of recipients survived one year.
One year after such transplantations, the outcomes are similar to those who receive hearts not infected with hepatitis C.
Donna Cryer advocates for many liver-related conditions as founder and CEO of the Global Liver Institute.
Personal struggles with liver disease led Donna Cryer to advocacy.
The risk of using an organ infected with hepatitis C are lower than ever—and could save patients months on organ waitlists.
This rapid regimen could open the door for more transplantations of HCV-infected organs.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.